These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia. Glazer WM; Hafez H Schizophr Res; 1990; 3(5-6):315-20. PubMed ID: 1980827 [TBL] [Abstract][Full Text] [Related]
4. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. Elkashef AM; Buchanan RW; Gellad F; Munson RC; Breier A Am J Psychiatry; 1994 May; 151(5):752-5. PubMed ID: 7909412 [TBL] [Abstract][Full Text] [Related]
5. Basal ganglia iron in tardive dyskinesia: an MRI study. Elkashef AM; Egan MF; Frank JA; Hyde TM; Lewis BK; Wyatt RJ Biol Psychiatry; 1994 Jan; 35(1):16-21. PubMed ID: 8167198 [TBL] [Abstract][Full Text] [Related]
9. Changing epidemiology of tardive dyskinesia: an overview. Jeste DV; Wyatt RJ Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344 [TBL] [Abstract][Full Text] [Related]
10. Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence. Gold R; Lenox RH J Clin Psychiatry; 1995 Oct; 56(10):476-83. PubMed ID: 7559375 [TBL] [Abstract][Full Text] [Related]
11. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Correll CU; Leucht S; Kane JM Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963 [TBL] [Abstract][Full Text] [Related]